1. China Stocks

  2. •

    Retail trade

  3. •

    Drugstore chains
Sipai Health Technology Co., Ltd.

Sipai Health Technology Co., Ltd.

0.16
EUR
0.00
(0.00%)
187.45MMarket Cap
Mar 23Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.36
3.54
4.55
36.63
7.32
7.14
3.44
- -
Basic EPS, GAAP
-0.78
-1.37
-4.9
-12.19
-0.4
-0.51
-0.21
- -
Free Cash Flow per Basic Share
-0.45
-0.27
-0.84
-1.72
-0.22
-0.11
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-1.32
-2.35
-7.12
2.41
2.13
1.6
1.25
1.25
Tangible Book Value per Share
-1.44
-2.47
-7.3
2.23
2
1.55
1.22
1.22
Basic Weighted Avg Shares
763
763
763
112
644
639
602
601
Sales/Revenue/Turnover
1,039
2,700
3,474
4,119
4,712
4,565
2,071
- -
Operating Margin (%)
-26.8
-14.05
-20.96
-14.88
-5.22
-6.12
-4.46
- -
Depreciation Expense
30
48
54
49
53
49
27
- -
Net Income, GAAP
-595
-1,043
-3,740
-1,371
-256
-324
-124
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-57.23
-38.63
-107.67
-33.27
-5.43
-7.09
-6
- -
Working Capital
621
1,679
1,657
1,640
1,301
944
572
572
LT Debt
45
37
53
39
39
26
13
13
Total Equity
-1,007
-1,792
-5,431
1,834
1,631
1,202
900
900
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
-14.8
-22.76
-11.49
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
20
14
10
LT Borrowings
- -
- -
- -
LT Finance Leases
26
11
13
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
764
750
749
Market Capitalization
3,832
3,166
1,540

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
1,980
1,539
1,263
Cash, Cash Equivalents & STI
920
598
618
Accounts Receivable, Net
261
215
155
Inventories
194
92
67
Total Current Liabilities
1,037
865
690
Payables & Accruals
- -
- -
- -
ST Debt
20
14
10
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
1.37%
-25.1%
Free Cash Flow
- -
-7.36%
-100.18%
Net Income, GAAP
- -
15.79%
-61.61%
Sales/Revenue/Turnover
- -
0.78%
-54.64%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
4,712
2024
- -
- -
4,565
2025
- -
- -
2,071

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.4
2024
- -
- -
-0.51
2025
- -
- -
-0.21

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Xu Guang Ma
Full Time Employees
3,131
Sector
Retail trade
Industry
Drugstore chains
Address
Tower 1, Kerry Enterprise Center Shanghai SH China 200063
IPO Date
Dec 23, 2022
Website
medbankshealthtech.com
Similar Companies
CVS Health Corporation (NYSE:CVS)
MatsukiyoCocokara & Co. (TSE:3088)
Guardian Pharmacy Services, Inc. (NYSE:GRDN)
TSURUHA Holdings, Inc. (TSE:3391)
MedPlus Health Services Ltd. (NSE:MEDPLUS)
Raia Drogasil S.A. (B3:RADL3)
Business
Sipai Health Technology Co., Ltd., also recognized as Medbanks Health Technology, functions as a prominent medical technology and health management enterprise within the People's Republic of China. This company delivers its services through three principal divisions: Specialty Pharmacy Operations, Clinical Research Support, and Health Coverage Solutions. The Specialty Pharmacy Operations segment manages specialized pharmacies, offering innovative medications, particularly for oncology and complex conditions, along with expert pharmacist guidance and a comprehensive pharmaceutical supply chain. In 2024, this division began a strategic restructuring to better align with the company's "health insurance plus healthcare management" model, shifting focus away from general medication distribution. The Clinical Research Support division assists pharmaceutical companies and trial institutions with site management organization services, encompassing trial feasibility, participant recruitment, data handling, and comprehensive on-site study support, including specialized medical imaging assessments. The Health Coverage Solutions division delivers insurance brokerage services to insurers and comprehensive health management programs for both insurance providers and corporate clients, including tailored "insurance + health + medical" offerings. Established in 2014, the company maintains its primary operational hubs across China, including Guangzhou, Shanghai, and Beijing.